$GILD News Wynn, Newmont lead gainers; Macy’s, Bed

New Post Public Reply Private Reply Replies (0) Message Board

Jan 9, 2015 at 1:03 PM

$GILD News

Wynn, Newmont lead gainers; Macy’s, Bed Bath & Beyond slump 11:05 a.m. Today - Sue Chang
Fifteen stocks for 2015, part 1 10:36 a.m. Today - The Trading Deck
AbbVie predicts sharp increase in earnings 4:56 p.m. Jan. 8, 2015 - MarketWatch.com
Gilead Sciences shares rise 2.4% 9:32 a.m. Jan. 6, 2015 - Sue Chang
Gilead to buy liver disease treatment from Germany's Phenex 8:39 a.m. Jan. 6, 2015 - Ciara Linnane
Gilead, CVS strike deal on Hepatitis C drugs 1:47 p.m. Jan. 5, 2015 - Russ Britt
Eight charts plot the year in finance 12:45 p.m. Dec. 30, 2014 - Ophir Gottlieb
Are consumers getting gouged on health care? 9:35 a.m. Dec. 30, 2014 - Russ Britt
S&P 500 rises to record, but Dow snaps 7-day win streak 4:24 p.m. Dec. 29, 2014 - Sara Sjolin
Manitowoc, Gilead climb; Tesla slips 11:12 a.m. Dec. 29, 2014 - Wallace Witkowski
Mon., Dec. 29, 2014: Watch Manitowoc Stock 10:32 a.m. Dec. 29, 2014 - MarketWatch
Gilead shares up 3% as Morgan Stanley upgrades to overweight 10:07 a.m. Dec. 29, 2014 - Ciara Linnane
Gilead shares up 2.9% in early trade 9:52 a.m. Dec. 29, 2014 - Ciara Linnane
Gilead upgraded to overweight from equal-weight at Morgan Stanley 9:52 a.m. Dec. 29, 2014 - Ciara Linnane
U.S. Stock Futures Fall, Following Europe's Lead 9:51 a.m. Dec. 29, 2014 - MarketWatch
Gilead Sciences, energy plays lead S&P advancers 9:34 a.m. Dec. 29, 2014 - Silvia Ascarelli
Why speculators see opportunity in younger, cyclical stocks 2:50 p.m. Dec. 26, 2014 - The Trading Deck
GoPro, Gilead Sciences, Celgene gain 11:27 a.m. Dec. 26, 2014 - MarketWatch
GoPro, Adamas climb, Cal-Maine slides 10:06 a.m. Dec. 24, 2014 - MarketWatch
Gilead's stock, up 2%, is early volume leader on Nasdaq 9:37 a.m. Dec. 24, 2014 - Tomi Kilgore

Gilled Buying Vertex Among Bold Biotech Stock Predictions for 2015 10:42 a.m. Today - TheStreet.com
Gilead Continues to Recover from Express Scripts Loss 10:04 a.m. Today - 247WallSt.com
Gilead: Focusing On The Expansion Of Its Liver Drug Portfolio 9:26 a.m. Today - Seeking Alpha
Trade-Ideas: Gilead (GILD) Is Today's Post-Market Leader Stock 5:37 p.m. Jan. 8, 2015 - TheStreet.com
AbbVie Predicts Big Profit Increase 4:52 p.m. Jan. 8, 2015 - The Wall Street Journal Interactive Edition
Hep C Drug Deal Raises Patient-Choice Concerns 3:51 p.m. Jan. 8, 2015 - The Wall Street Journal Interactive Edition
Five Stock Picks for 2015 3:00 p.m. Jan. 8, 2015 - FOXBusiness
Biotech Investors Guide and Preview to the J.P. Morgan Healthcare Conference Part 1 1:09 p.m. Jan. 8, 2015 - TheStreet.com
The 2015 Calendar Of NASH Trial Catalysts: Gilead Adds To Its NASH Arsenal 8:19 a.m. Jan. 8, 2015 - Seeking Alpha
Gilead to Purchase Liver Disease Program from Phenex - Analyst Blog 4:45 p.m. Jan. 7, 2015 - Zacks.com
Wells Fargo Top Biotech Stocks for 2015 2:10 p.m. Jan. 7, 2015 - 247WallSt.com
Gilead's simtuzumab an Orphan Drug for rare liver disease 1:39 p.m. Jan. 7, 2015 - Seeking Alpha
Gilead Sciences Gains Orphan Drug Status For Liver Treatment, Shares Move Higher 10:27 a.m. Jan. 7, 2015 - benzinga.com
Gilead Fires Back 10:09 a.m. Jan. 7, 2015 - Seeking Alpha
Analyst’s 8 Top Health Care Stocks for 2015 9:43 a.m. Jan. 7, 2015 - 247WallSt.com
Biotech Stock Roundup: Kite Flies High on Amgen Deal, Isis Soars on J&J Collaboration - Analyst Blog 9:09 a.m. Jan. 7, 2015 - Zacks.com
Galectin up on Phase 1 results in NASH 8:50 a.m. Jan. 7, 2015 - Seeking Alpha
Update: Gilead Acquires Another Drug Candidate 8:50 a.m. Jan. 7, 2015 - Seeking Alpha
Gilead Sciences' New Contract Exclusivity Helps The Shares Advance 8:10 a.m. Jan. 7, 2015 - Seeking Alpha
'Fast Money' Recap: Another Day, Another Market Drop on Falling Oil 5:00 a.m. Jan. 7, 2015 - TheStreet.com

Reveal Earnings Forecast for Arena Pharmaceuticals, Petrobras, Alibaba, Apple, Gilead Sciences, and Applied Materials 8:45 a.m. Today - PR Newswire - PRF
Earnings Forecast for Apple, Alibaba, Twitter, Gilead Sciences, Michael Kors, and Tesla 8:45 a.m. Jan. 7, 2015 - PR Newswire - PRF
Biotechs to Follow in 2015 off Fresh Insider Moves 10:00 a.m. Jan. 6, 2015 - ACCESSWIRE
Gilead Sciences Announces Acquisition of Phenex Pharmaceuticals’ Development Program for Non-Alcoholic Steatohepatitis (NASH) and Other Liver Diseases 8:31 a.m. Jan. 6, 2015 - BusinessWire - BZX
Factors Moving Markets: Complementary Reports on United Parcel Service, Gilead, Manitowoc, EMC Corporation, and LiveDeal 9:10 a.m. Dec. 30, 2014 - PR Newswire - PRF
Biotech Stocks Technical Data -- Gilead Sciences, ImmunoGen, Exelixis, Cubist Pharma, and Vanda Pharma 8:55 a.m. Dec. 30, 2014 - PR Newswire - PRF
Gilead Announces Amended Agreements With Janssen to Develop and Commercialize Tenofovir Alafenamide-Based Single Tablet Regimens for HIV Treatment 8:30 a.m. Dec. 29, 2014 - BusinessWire - BZX
Critical Alerts For Achillion Pharmaceuticals, AT&T, Peabody Energy, Gilead Sciences and Facebook Released By InvestorsObserver 9:31 a.m. Dec. 23, 2014 - PR Newswire - PRF
AHF Lauds Express Scripts for Dropping Gilead’s Sovaldi in Favor of Cheaper Hepatitis C Treatment 9:01 a.m. Dec. 23, 2014 - BusinessWire - BZX
Pharmaceuticals, Medicines, Supplements and Drug Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 325400 8:15 a.m. Dec. 23, 2014 - PR Newswire - PRF
Reveal Earnings Forecast for Apple, Halliburton, American Realty Capital Properties, Gilead Sciences, Zynga, and Bank of America 8:45 a.m. Dec. 16, 2014 - PR Newswire - PRF
Philippe C. Bishop, MD, to Join Gilead as Senior Vice President, Hematology and Oncology Therapeutics 8:30 a.m. Dec. 15, 2014 - BusinessWire - BZX
Critical Alerts For Abercrombie & Fitch, Whole Foods Market, Gilead Sciences, JC Penney and Activision Blizzard Released By InvestorsObserver 9:31 a.m. Dec. 10, 2014 - PR Newswire - PRF
Class Action Lawsuit Challenges the Exorbitant Pricing of Gilead's Hepatitis-C Drug Sovaldi 6:39 p.m. Dec. 9, 2014 - PR Newswire - PRF
BetterInvesting Magazine Releases February Stock To Study And Undervalued Stock Choices For Investors' Informational And Educational Use 4:43 p.m. Dec. 9, 2014 - PR Newswire - PRF
Biogen Idec and Gilead Sciences Join the National Pharmaceutical Council 9:15 a.m. Dec. 9, 2014 - PR Newswire - PRF
Gilead Presents Follow-up Data from Zydelig Registrational Studies in Patients with Chronic Lymphocytic Leukemia, Follicular Lymphoma and Small Lymphocytic Lymphoma 10:00 a.m. Dec. 8, 2014 - BusinessWire - BZX
Reveal Earnings Forecast for Gilead Sciences, Apple, Transocean, Halliburton, Ctrip, and Sirius XM 8:45 a.m. Dec. 8, 2014 - PR Newswire - PRF
Reveal Earnings Forecast for Gilead Sciences, Kinder Morgan, JD.Com, Sirius XM, Apple, and Plug Power 8:45 a.m. Dec. 4, 2014 - PR Newswire - PRF
Earnings Forecast Reports for Apple, Alibaba, Kinder Morgan, Gilead Sciences, Plug Power, and Yahoo 8:45 a.m. Dec. 2, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Baidu Faces Class Action: Investors Push Against Fraud Allegations

Baidu Under Fire for Alleged Misleading Statements Here's a fresh slice of drama straight outta the corporate trenches: Baidu, Inc. (NASDAQ: BIDU) finds itself tangled in a securities fraud lawsuit that’s causing a ruckus across investor circles. Schall, Brown & Schwartz LLP, those heavyweight gladiators in shareholder rights, are calling on grieved investors to step up...

Food Trends Tease: 2027 sofi™ Awards' 75 Finalists

The Specialty Food Scene Heats Up Today’s world doesn’t rest when it comes to innovation, and the same goes for the tantalizing realm of specialty foods. Hot off the press, the Specialty Food Association (SFA) just rolled out the red carpet for its 75 finalists in the 2027 sofi™ Awards. These are the future taste shapers set to take center stage at the Winter...

Kenneth Smith Takes Helm for Trends Int’l Expansion

Tired of the Same Old Leadership Shuffle? Here Comes Kenneth Smith Look, I’ve seen my share of execs come and go, usually dragging the same old briefcase of stale ideas. But Kenneth Smith stepping up as CEO of Trends International? Now that’s got some real teeth to it. Come May 2026, he’s the guy at the helm, and he's got one hell of a to-do list. Smith's Roadmap: A...

LINC Lawsuit: Boardroom Stumbles Spark Investor Action

Class Action Kickoff: Lincoln's Educational Curveball No one fancies home runs when the ball’s out of sight, and that’s probably how some investors in Lincoln Educational Services Corporation (NASDAQ: LINC) are feeling right now. A group of shareholders has pulled back the curtain on what they believe are more than just administrative hiccups—allegations of...

Nest Health Appoints Peter Morrison for Multistate Expansion

Peter Morrison Steps Up as Chief Growth Officer You know, it's not every day you see a move as gutsy as Nest Health's recent appointment of Peter Morrison. They're shaking up the Medicaid space, aiming to redefine primary care for families with limited resources. Morrison, coming from heavyweights like UnitedHealthcare and Centene, isn't your typical pencil-pusher. He’s...

Senté’s Heparan Sulfate Pairing: Peer-Reviewed Success

Senté's Science-Driven Approach in Skincare Alright, cutting through the skincare noise, Senté Labs has pulled off something impressive—not just another jar of promises but actual, peer-reviewed science backing their Defense C Serum. Published in the Journal of Cosmetic Dermatology, this study isn't just talk about ingredients; it's a show of real results. This isn't...

GELITA Showcases Collagen Innovations at SupplySide 2026

Collagen Solutions Front and Center First up, a little chat about collagen might be in order. For folks not tied into the science side, it sounds like a trendy wellness potion. But here comes GELITA at SupplySide Global 2026, showing it's the real McCoy. Nestled in Booth #4565, they're laying out a spread of next-gen collagen innovations aimed at everything from wound...

QFIN Faces Class Action: Investors' Role Explored

Cracks in the Facade: QFIN's Legal Mess You're cruising down the usual market lanes when—bam!—news breaks that Qfin Holdings, Inc. (NASDAQ: QFIN) finds itself hip-deep in a class action lawsuit. Seems like our pals at Schall, Brown & Schwartz LLP have thrown the gauntlet down, with claims of some serious smoke and mirrors during the March to August stretch of 2026....

Kansai Medical Ushers in New Era of Cancer Research

Breaking Ground in Cancer Treatment Trials I've seen some thrilling breakthroughs in my time following the pharmaceutical industry, but what Kansai Medical University and Daiichi Sankyo are doing elevates the game. They're rolling out the first patient dose of DS1025 in Osaka, Japan—a move that marks the onset of a global Phase 1 clinical trial. This is no ordinary...

De¹ Unveils Tokenization Model on BNB Chain

De¹'s Bold Move into Enhanced Digital Finance Just when you thought the financial landscape couldn’t get any more complex, De¹ steps into the ring with its Tokenized Asset World on the BNB Chain—a move that's stirring the pot of tokenized finance in more ways than one. For old-school investors who thrive on waving outlandish stock bets, this crypto narrative is a...